A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSIS

By Grubic N.   Stegnar M.   Peternel P.   Kaider A.   Binder B.R.  

Thrombosis Research, Vol. 84, Iss. 6, 1996-12 ,pp. : 431-443

Elsevier

Access to resources Recommend Favorite

4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Insertion/Deletion Polymorphism of the Tissue-Type Plasminogen Activator Gene in Atherothrombotic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 4, 2001-05 ,pp. : 294-299

Karger

Access to resources Recommend Favorite

Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G polymorphism and metabolic/proinflammatory factors in polycystic ovary syndrome

By Sales MF   Sóter MO   Candido AL   Fernandes AP   Oliveira FR   Ferreira ACS   Sousa MO   Ferreira CN   Gomes KB  

Gynecological Endocrinology, Vol. 29, Iss. 10, 2013-10 ,pp. : 936-939

Informa Healthcare

Access to resources Recommend Favorite

The Effect of Number of Days in Culture and Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Genotype on PAI-1 Antigen Release by Cultured Human Umbilical Vein Endothelial Cells - Identification by morphologic and immunologic criteria

By McCormack L.J.   Semple J.I.   Stickland M.H.   Barrett J.H.   Grant P.J.  

Thrombosis Research, Vol. 92, Iss. 5, 1998-12 ,pp. : 199-206

Elsevier

Access to resources Recommend Favorite

Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells

By Grimsley P.G.   Normyle J.F.   Brandt R.A.   Joulianos G.   Chesterman C.N.   Hogg P.J.   Owensby D.A.  

Thrombosis Research, Vol. 79, Iss. 4, 1995-08 ,pp. : 353-361

Elsevier

Access to resources Recommend Favorite